Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Niet geschikt voor kinderen, zwangere of zogende vrouwen
Journal of affective disorders , 339 , 860866
ICARUS-Lung01 is a multicentre, single-arm, phase II trial evaluating Dato-DXd in refractory NSCLC (including patients with an actionable genomic alteration) and progressing to at least one line of immunotherapy and platinum-doublet regimen
AOD 9604 (Anti-Obesity Drug 9604) is a modified derivative of HGH Fragment 176-191, originally developed by an Australian pharmaceutical company as a candidate compound for obesity research
US$ 28.16
US$ 22.15
US$ 21.41
US$ 27.73
